Pharmacy team develops 3D-printed bandage to help heal chronic wounds
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Jun-2026 23:15 ET (29-Jun-2026 03:15 GMT/UTC)
Mosquitoes are increasingly becoming resistant to current insecticides, leading to a pressing need for new methods to prevent mosquito bites — and the potential transmission of disease. New research by an international team, including researchers at the University of Washington, reveals that Aedes aegypti mosquitoes use a specific sensory receptor to detect and avoid borneol (pronounced "bor-nee-ohl"), an organic compound found in several aromatic plants, including camphor trees, rosemary and other aromatic herbs.
A study reveals that a rare pediatric liver cancer arises from multiple liver cancer cells that independently undergo tumor-type transitions into other tumor types.
An international consortium of scientists has uncovered new insights into coral ecosystems, revealing that different coral species host their own distinct communities of microbes.
The research, which involved a team at University of Galway, shows that coral reefs harbour diverse microbes and produce chemicals with promising potential for future application in medicine and biotechnology.
Deciding if and when to pursue deep brain stimulation (DBS) can be overwhelming for people with Parkinson’s disease. While DBS is one of the most effective interventions for movement symptoms, it’s also among the most complex. DBS uses a surgically implanted, battery‑powered device to send electrical signals to areas of the brain that control movement.
To make this decision easier, experts at the University of Colorado Anschutz created the first evidence-based decision tool for patients designed to improve patients’ understanding of DBS and boost their confidence as they weigh treatment options. Their results, published in the Journal of Parkinson’s Disease, show that the majority of patients reported it was helpful in their decision-making process, they were satisfied with the tool and would recommend it to others.
“We designed this to support real shared decision‑making between patients and doctors, not just information‑sharing. What we found is that patients at every stage of the DBS journey found it useful,” said the study’s first author Michelle Fullard, MD, MSCE, Director of Clinical Research at the CU Anschutz Movement Disorders Center. “We see this as a tool that patients can use on their own so they’re coming to the table with knowledge about the surgery while talking to their doctors.”
Dr. Thomas Hartung, Director of the Center for Alternatives to Animal Testing (CAAT) at the Johns Hopkins Bloomberg School of Public Health, has endorsed the public launch of ToxIndex, an agentic AI platform developed by Insilica Inc. that produces comprehensive, source-traceable toxicological risk assessments in just a few hours.